Bioventus Inc. (BVS) is a global leader in the rapidly-growing field of orthobiologics, the science behind natural treatments that facilitate the body's intrinsic ability to heal bone and tissue injuries. The company, founded in 2012, is listed on NASDAQ, under the ticker symbol BVS. Bioventus is focused on developing, manufacturing, and marketing a wide array of clinically proven orthobiologic solutions to improve and speed up bone healing.
Headquartered in Durham, North Carolina, Bioventus pioneers minimally invasive treatments that support the body’s natural healing process. Their product portfolio includes devices, supplements, and injections specifically designed to help patients recover from orthopedic conditions such as osteoarthritis and degenerative disc disease.
Bioventus' products are used by orthopedic specialists, sports medicine doctors, rheumatologists, and other healthcare professionals in over 50 countries worldwide for patient care. Its leading product offering includes the EXOGEN® Ultrasound Bone Healing System, which accelerates the healing of fresh fractures, and is used as a non-invasive treatment for specific non-unions.
Other innovative solutions from Bioventus include DUROLANE and GELSYN-3, which are injections designed to provide pain relief for patients with osteoarthritis. The company also offers SIGNAFUSE® and OSTEOAMP®, for bone graft and spine fusion surgeries, and SUPARTZ FX, a natural solution for knee osteoarthritis.
With total employees hovering around 700, Bioventus has shown a firm commitment to scientific research and innovation. The company's research & development efforts have resulted in 15 FDA-approved products, making it an industry leader in bringing new treatments to market.
Over the past years, Bioventus has grown significantly through a mix of organic growth and strategic acquisitions, reinforcing its commitment to delivering innovative, cost-effective solutions that help patients regain active lifestyles.
Additionally, Bioventus is dedicated to corporate social responsibility endeavors, primarily focusing on promoting diverse and inclusive workplaces. It is also committed to a variety of environmental, social, and governance (ESG) matters.
To conclude, Bioventus Inc. is an orthobiologics company dedicated to innovation, quality, integrity, and improving patient outcomes. By harnessing the power of the body's own healing abilities, Bioventus is paving the way for a future of minimally invasive, natural treatments for common orthopedic issues.